Filing Details

Accession Number:
0001161697-12-000408
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-29 18:00:51
Reporting Period:
2012-05-24
Filing Date:
2012-05-29
Accepted Time:
2012-05-29 18:00:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceutical Partners Inc. CPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1121608 Md E Hubert Huckel 355 Alhambra Circle, Suite 1500
Coral Gables FL 33134
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2012-05-24 125,000 $0.80 1,304,134 No 4 P Indirect .
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect .
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to purchase common stock Acquisiton 2012-05-24 125,000 $0.00 125,000 $1.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,000 2012-05-30 2017-05-30 No 4 P Indirect
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Options to purchase common stock $1.07 2011-12-16 2016-12-16 824,608 824,608 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-12-16 824,608 824,608 Direct
Footnotes
  1. Securities were sold as units, each consisting of one share of the Issuer's common stock and one five-year warrant to purchase one share of the Issuer's common stock, at a price of $0.80 per unit.
  2. Securities are held in a Grantor Retained Annuity Trust, the Trustee of which is Dr. Huckel.